The HillCenter·
White House bats down speculation that Trump got access to Eli Lilly obesity drug for ‘compassionate use’
White House officials on Tuesday shot down a report speculating that President Trump gained access to the retatrutide weight-loss drug under the Food and Drug Administration’s (FDA) “compassionate use program.” The retatrutide drug is manufactured by Eli Lilly and is not FDA approved, however, one person gained access to the prescription through a program that...
Read at The Hill →
